|
Evaluation of effectiveness of GSK Biologicals’ pneumococcal conjugate vaccine 1024850A against invasive disease |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) |
111442 |
NCT00861380 2008-005149-48 |
Infections, Streptococcal |
Phase 3 |
|
|
|
|
A nested study 112595 was conducted. |
September 2015 |